Introduction: Direct laryngoscopy and endotracheal intubation are a noxious stimulus and induces sympathomimetic responses. Although properly tolerated in normal and healthy subjects, it can impose serious arrhythmias, left ventricular failure, myocardial ischemia, or rupture of cerebral aneurysm in vulnerable patients. Various techniques are currently working to attenuate this response, but, so far, none of them have been proven to be superior. Esmolol and Lignocaine; attenuate those responses however are related to some untoward outcomes such as bradycardia and hypotension. In low doses, the chances of those expected untoward outcomes are relatively low. Aim and Objectives: We designed this prospective clinical education to assess and compare the efficacy of intravenous Esmolol and Lignocaine in attenuating sympathomimetic responses to laryngoscopy and endotracheal intubation. Methods: After the Institutional Ethics Committee approval, 52 consenting patients of ASA physical repute I or II of age between 20 and 60 years, scheduled for surgeries requiring general anesthesia, remained randomly owed to two groups; Group E and Group L, given 2 mg/kg of inj. Esmolol intravenously and inj. Lignocaine 2 mg/kg, respectively, 2 min before intubation. Final outcome variables such as heart rate (HR), systolic blood pressure (BP), diastolic BP, and mean arterial pressure (MAP) had been recorded and compared between the two groups immediately after intubation (AI) and then at 1, 3, and 5 min AI. Results: There was no statistically huge distinction regarding the demographic profiles of both the study groups. There has been a substantial rise in mean HR in the lignocaine group all through laryngoscopy and intubation, which did not settle to baseline level even after 5 min (p<0.0001). In the esmolol group, a significant attenuation of HR was observed immediately AI and 1, 3, and 5 min following intubation. MAP was well controlled in the esmolol group. Throughout the study period, readings of mean arterial pressure were much higher in esmolol group. In the lignocaine group, the values of study parameters were higher than the baseline at every point of time. Diastolic BP was elevated in both groups. Conclusion: Esmolol was found to be more effective for attenuation of hemodynamic tension response to laryngoscopy and intubation when compared with Lignocaine. However, Lignocaine is also safe and effective to some extent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.